Defiance Daily Target 2X Long LLY ETF (LLYX)

NYSEARCA: LLYX · Real-Time Price · USD
15.81
-1.42 (-8.24%)
Jan 17, 2025, 4:00 PM EST - Market closed
-8.24%
Assets $16.81M
Expense Ratio 1.29%
PE Ratio n/a
Shares Out 975,000
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return n/a
Volume 296,853
Open 16.91
Previous Close 17.23
Day's Range 15.80 - 16.91
52-Week Low 15.78
52-Week High 31.19
Beta n/a
Holdings n/a
Inception Date Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

Asset Class Equity
Stock Exchange NYSEARCA
Ticker Symbol LLYX
ETF Provider Defiance

News

New Defiance Single-Stock ETF Tracks NOVO Nordisk Performance

Defiance ETFs added another single-stock ETF to its lineup, bringing the total number of 2x leveraged single-stock funds in its offering to five.

Other symbols: MSTXNVOXAVGXSMCX
6 weeks ago - ETF Trends